Standard Chemical & Pharmaceutical Co., Ltd. (TPE:1720)

Market Cap	11.24B +1.5%
Revenue (ttm)	7.02B +3.4%
Net Income	927.66M +5.4%
EPS	5.18 +5.3%
Shares Out	178.70M
PE Ratio	12.14
Forward PE	n/a
Dividend	2.80 (4.41%)
Ex-Dividend Date	Aug 6, 2025

Volume	352,911
Average Volume	599,391
Open	63.50
Previous Close	63.50
Day's Range	62.90 - 63.90
52-Week Range	51.20 - 66.60
Beta	0.04
RSI	51.59
Earnings Date	Feb 25, 2026

About TPE:1720

Standard Chemical & Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells pharmaceutical products in Taiwan and internationally. The company offers Chinese and western medicine, cosmetics, beverage, normal instruments, and medical instruments. It also sells various medical supplements, as well as preventive medicine; and imports and exports various medical products, medicine, supplements, nourishment, and function food. In addition, the company is involved in wholesale of multi-function printers and information softwa...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1967
• Country: Taiwan
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 1720

Financial Performance

In 2025, TPE:1720's revenue was 7.02 billion, an increase of 3.44% compared to the previous year's 6.79 billion. Earnings were 927.66 million, an increase of 5.36%.